UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 140

Sortiert nach

Placenta Accreta Spectrum and Hypertensive Disorders of Pregnancy: Concerns Regarding the Difference in Length of Pregnancy

Reproductive sciences (Thousand Oaks, Calif.), 2023-01, Vol.30 (1), p.330-331

2023

Volltextzugriff (PDF)

Human papillomavirus genotype contribution to cervical cancer and precancer: Implications for screening and vaccination in Japan

Cancer science, 2020-07, Vol.111 (7), p.2546-2557

2020

Volltextzugriff (PDF)

Ex vivo chemosensitivity assay using primary ovarian cancer organoids for predicting clinical response and screening effective drugs

Human cell : official journal of Human Cell Research Society, 2023-03, Vol.36 (2), p.752-761

2023

Volltextzugriff (PDF)

Efficacy and safety of standard of care with/without bevacizumab for platinum‐resistant ovarian/fallopian tube/peritoneal cancer previously treated with bevacizumab: The Japanese Gynecologic Oncology Group study JGOG3023

Cancer science, 2022-01, Vol.113 (1), p.240-250

2022

Volltextzugriff (PDF)

Twenty-five-year mortality trends of four major histological subtypes of cervical cancer: a population-based study using the Osaka cancer registry data

Frontiers in oncology, 2023-11, Vol.13, p.1233354-1233354

2023

Volltextzugriff (PDF)

Pembrolizumab monotherapy in Japanese patients with advanced ovarian cancer: Subgroup analysis from the KEYNOTE‐100

Cancer science, 2020-04, Vol.111 (4), p.1324-1332

2020

Volltextzugriff (PDF)

Port‐site hernia: A potentially severe complication of minimally invasive surgery

Clinical case reports, 2023-07, Vol.11 (7), p.e7391-n/a

2023

Volltextzugriff (PDF)

Impact of lymphadenectomy in patients with locally recurrent or persistent cervical cancer treated with salvage hysterectomy

The journal of obstetrics and gynaecology research, 2023-02, Vol.49 (2), p.717-724

2023

Volltextzugriff (PDF)

Risk assessment in the patients with uterine cervical cancer harboring intermediate risk factors after radical hysterectomy: a multicenter, retrospective analysis by the Japanese Gynecologic Oncology Group

International journal of clinical oncology, 2022-09, Vol.27 (9), p.1507-1515

2022

Volltextzugriff (PDF)

Bevacizumab combined with platinum–taxane chemotherapy as first-line treatment for advanced ovarian cancer: a prospective observational study of safety and efficacy in Japanese patients (JGOG3022 trial)

International journal of clinical oncology, 2019-01, Vol.24 (1), p.103-114

2019

Volltextzugriff (PDF)

miR-92a Inhibits Peritoneal Dissemination of Ovarian Cancer Cells by Inhibiting Integrin α5 Expression

The American journal of pathology, 2013-05, Vol.182 (5), p.1876-1889

2013

Volltextzugriff (PDF)

Significance of the Number and the Location of Metastatic Lymph Nodes in Locally Recurrent or Persistent Cervical Cancer Patients Treated with Salvage Hysterectomy plus Lymphadenectomy

Current oncology (Toronto), 2022-07, Vol.29 (7), p.4856-4867

2022

Volltextzugriff (PDF)

Population-Based Survival Analysis of Stage IVB Small-Cell Neuroendocrine Carcinoma in Comparison to Major Histological Subtypes of Cervical Cancer

Current oncology (Toronto), 2023-10, Vol.30 (11), p.9428-9436

2023

Volltextzugriff (PDF)

Reduction in HPV16/18 prevalence among young women with high‐grade cervical lesions following the Japanese HPV vaccination program

Cancer science, 2019-12, Vol.110 (12), p.3811-3820

2019

Volltextzugriff (PDF)

Dedifferentiation of neuroendocrine carcinoma of the uterine cervix in hypoxia

Biochemical and biophysical research communications, 2020-04, Vol.524 (2), p.398-404

2020

Volltextzugriff (PDF)

Comparison of the Survival Outcomes of Minimally Invasive Surgery with Open Surgery in Patients with Uterine-Confined and Node-Negative Cervical Cancer: A Population-Based Study

Cancers, 2023-05, Vol.15 (10), p.2756

2023

Volltextzugriff (PDF)

The Effect of Surgeon Volume on the Outcome of Laser Vaporization: A Single-Center Retrospective Study

Current oncology (Toronto), 2022-05, Vol.29 (5), p.3770-3779

2022

Volltextzugriff (PDF)

Placenta Previa Complicated with Endometriosis: Contemporary Clinical Management, Molecular Mechanisms, and Future Research Opportunities

Biomedicines, 2021-10, Vol.9 (11), p.1536

2021

Volltextzugriff (PDF)

Heterogenous chemosensitivity of a panel of organoid lines derived from small cell neuroendocrine carcinoma of the uterine cervix

Human cell : official journal of Human Cell Research Society, 2021-05, Vol.34 (3), p.889-900

2021

Volltextzugriff (PDF)

Herlyn-Werner-Wunderlich syndrome (HWWS)-associated gynecological malignancies: A case report and literature review

Gynecologic oncology reports, 2022-10, Vol.43, p.101051, Article 101051

2022

Volltextzugriff (PDF)

An open-label, randomized, phase II trial evaluating the efficacy and safety of standard of care with or without bevacizumab in platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer patients previously treated with bevacizumab for front-line or platinum-sensitive ovarian cancer: rationale, design, and methods of the Japanese Gynecologic Oncology Group study JGOG3023

BMC cancer, 2018-07, Vol.18 (1), p.771-771, Article 771

2018

Volltextzugriff (PDF)

Drug screening and grouping by sensitivity with a panel of primary cultured cancer spheroids derived from endometrial cancer

Cancer science, 2016-04, Vol.107 (4), p.452-460

2016

Volltextzugriff (PDF)

Placenta Accreta Spectrum Disorder Complicated with Endometriosis: Systematic Review and Meta-Analysis

Biomedicines, 2022-02, Vol.10 (2), p.390

2022

Volltextzugriff (PDF)

Surgical Management for Transposed Ovarian Recurrence of Cervical Cancer: A Systematic Review with Our Experience

Current oncology (Toronto), 2022-09, Vol.29 (10), p.7158-7170

2022

Volltextzugriff (PDF)

Early reduction of glucose uptake after cisplatin treatment is a marker of cisplatin sensitivity in ovarian cancer

Cancer science, 2010-10, Vol.101 (10), p.2171-2178

2010

Volltextzugriff (PDF)

1 – 25 von 140

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(119)
Mit Volltextzugriff
(123)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(104)
Life Sciences & Biomedicine
(99)
Humans
(67)
Female
(62)
Oncology
(55)
Middle Aged
(35)
Cervical Cancer
(34)
Adult
(29)
Aged
(28)
Obstetrics & Gynecology
(26)
Retrospective Studies
(20)
Survival
(20)
Uterine Cervical Neoplasms - Pathology
(19)
Surgery
(18)
Chemotherapy
(17)
Biological And Medical Sciences
(16)
Neoplasm Staging
(16)
Cancer
(15)
Cervix
(15)
Medical Sciences
(14)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Placenta Accreta Spectrum and Hypertensive Disorders of Pregnancy: Concerns Regarding the Difference in Length of Pregnancy

Human papillomavirus genotype contribution to cervical cancer and precancer: Implications for screening and vaccination in Japan

Ex vivo chemosensitivity assay using primary ovarian cancer organoids for predicting clinical response and screening effective drugs

Efficacy and safety of standard of care with/without bevacizumab for platinum‐resistant ovarian/fallopian tube/peritoneal cancer previously treated with bevacizumab: The Japanese Gynecologic Oncology Group study JGOG3023

Twenty-five-year mortality trends of four major histological subtypes of cervical cancer: a population-based study using the Osaka cancer registry data

Pembrolizumab monotherapy in Japanese patients with advanced ovarian cancer: Subgroup analysis from the KEYNOTE‐100

Port‐site hernia: A potentially severe complication of minimally invasive surgery

Impact of lymphadenectomy in patients with locally recurrent or persistent cervical cancer treated with salvage hysterectomy

Risk assessment in the patients with uterine cervical cancer harboring intermediate risk factors after radical hysterectomy: a multicenter, retrospective analysis by the Japanese Gynecologic Oncology Group

Bevacizumab combined with platinum–taxane chemotherapy as first-line treatment for advanced ovarian cancer: a prospective observational study of safety and efficacy in Japanese patients (JGOG3022 trial)

miR-92a Inhibits Peritoneal Dissemination of Ovarian Cancer Cells by Inhibiting Integrin α5 Expression

Significance of the Number and the Location of Metastatic Lymph Nodes in Locally Recurrent or Persistent Cervical Cancer Patients Treated with Salvage Hysterectomy plus Lymphadenectomy

Population-Based Survival Analysis of Stage IVB Small-Cell Neuroendocrine Carcinoma in Comparison to Major Histological Subtypes of Cervical Cancer

Reduction in HPV16/18 prevalence among young women with high‐grade cervical lesions following the Japanese HPV vaccination program

Dedifferentiation of neuroendocrine carcinoma of the uterine cervix in hypoxia

Comparison of the Survival Outcomes of Minimally Invasive Surgery with Open Surgery in Patients with Uterine-Confined and Node-Negative Cervical Cancer: A Population-Based Study

The Effect of Surgeon Volume on the Outcome of Laser Vaporization: A Single-Center Retrospective Study

Placenta Previa Complicated with Endometriosis: Contemporary Clinical Management, Molecular Mechanisms, and Future Research Opportunities

Heterogenous chemosensitivity of a panel of organoid lines derived from small cell neuroendocrine carcinoma of the uterine cervix

Herlyn-Werner-Wunderlich syndrome (HWWS)-associated gynecological malignancies: A case report and literature review

Drug screening and grouping by sensitivity with a panel of primary cultured cancer spheroids derived from endometrial cancer

Placenta Accreta Spectrum Disorder Complicated with Endometriosis: Systematic Review and Meta-Analysis

Surgical Management for Transposed Ovarian Recurrence of Cervical Cancer: A Systematic Review with Our Experience

Early reduction of glucose uptake after cisplatin treatment is a marker of cisplatin sensitivity in ovarian cancer

Suchergebnisse filtern